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Antimicrobial Efficacy and Synergy 
of Metal Ions against Enterococcus 
faecium, Klebsiella pneumoniae 
and Acinetobacter baumannii in 
Planktonic and Biofilm Phenotypes
Misha Y. Vaidya1, Andrew J. McBain  2, Jonathan A. Butler1, Craig E. Banks1 &  
Kathryn A. Whitehead1
The effects of metal ion solutions (silver, copper, platinum, gold and palladium) were determined 
individually and in combination against Enterococcus faecium, Acinetobacter baumannii and Klebsiella 
pneumoniae. Platinum, gold and palladium showed the greatest antimicrobial efficacy in zone of 
inhibition (ZoI) assays. When tested in combinations using ZoI assays, gold/platinum, gold/palladium 
and platinum/palladium were indicative of synergy. Microbial inhibitory concentration demonstrated 
platinum and gold against Enterococcus faecium, platinum against Klebsiella pneumoniae and platinum 
and silver against Acinetobacter baumannii were optimal. Minimal bactericidal concentrations 
determined the greatest bactericidal activity was again platinum gold and palladium against all three 
bacteria. Fractional Inhibitory Concentration (FIC) studies demonstrated that the silver/platinum 
combination against Enterococcus faecium, and silver/copper combination against Acinetobacter 
baumannii demonstrated antimicrobial synergy. Following crystal violet biofilm assays for single metal 
ion solutions, antimicrobial efficacies were demonstrated for all the metals against all the bacteria 
Synergistic assays against biofilms demonstrated gold/palladium, gold/platinumand platinum/
palladium resulted in the greatest antimicrobial efficacy. Overall, platinum, palladium and gold metal 
ion solutions in individual use or combination demonstrated the greatest antimicrobial efficacies 
against planktonic or biofilm bacteria. This work demonstrates the potential for using a range of metal 
ions, as biocidal formulations against both planktonic or biofilm bacteria.
The antimicrobial properties of metals have been recognised throughout the history of medicine and healthcare1. 
The application of metals in medicine was common until the discovery of antibiotics. Nevertheless, at the begin-
ning of the twenty-first century, a rapid increase in antimicrobial resistance has been observed, which has corre-
sponded with a lack of new antibiotic drugs. To reduce the transmission of potentially infectious microorganisms, 
there has been a revival of interest in the utilization of metals as antimicrobial/biocidal agents2.
There is now a need for alternative biocidal formulations that may be used as active antimicrobials3, 4. Biocidal 
products as outlined in the EU Biocides Directive (98/8/EC), are those that are intended to destroy, render harm-
less, prevent the action of, or otherwise exert a controlling effect on any harmful organism by chemical or biolog-
ical means (i.e. disinfectants, antiseptics and preservatives)2. Metal surfaces such as silver (Ag) and copper (Cu) 
have shown antimicrobial efficacies that may control bacterial transmission and infection risks in laboratory 
settings and hospital environments5, 6. Palladium (Pd) alloys have also been considered as potential materials 
for use as temporary implants to prevent cardiovascular disease infections7. Platinum (Pt) possesses metallurgic 
properties that enable it for use as an antimicrobial in medical implants, such as cardiovascular defibrillators or 
hip and knee implants and catheters8. Gold (Au) nanoparticles have been previously explored for use as delivery 
vehicles for thioguanine9, and various antibiotics10–12. The synergistic effects of metals or their complexes have 
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also been demonstrated13, 14. For example, phosphogold dithiocarbonate complexes have demonstrated to have 
comparable antimicrobial potency when compared to various antibiotics such as chloramphenicol against resist-
ant pathogens13. An antimicrobial effect has also been demonstrated for Au+3 whereby an increase in bacterial 
inhibition was demonstrated when combined with cephalexin, clindamycin or vancomycin against Escherichia 
coli and Pseudomonas aeruginosa14.
Enterococcus faecium is an emergent Gram-positive opportunistic pathogen that is the causative agent of sev-
eral nosocomial infections including complicated urinary tract infections and surgical wound infections15–17. 
Enterococcus is difficult to inactivate due to its high level recalcitrance and tolerance of a wide range of growth 
conditions. E. faecium can survive for long periods of time on environmental surfaces including medical equip-
ment, bedrails and door knobs15, 18, 19. Klebsiella pneumoniae is a Gram-negative microorganism that has a large 
polysaccharide capsule surrounding the bacterial cell, which both protects the bacteria and acts as a barrier to 
antimicrobial agents20. This species is an opportunistic pathogen principally related with hospital-acquired infec-
tions including those of the respiratory and urinary tract21. A. baumannii also has a role in hospital-acquired 
infections particularly in causing bacteremia, pneumonia, urinary tract and wound infections22. These bacterial 
strains also have the ability to form biofilms on abiotic and biotic substrates, which may be problematic on cath-
eters, potentially leading to an increase in transmission and infection risks. This may result in increased patient 
morbidity and mortality12–14, 23. In order to determine the potential of a range of metal ions for their use as bioc-
idal agents, a pilot study was carried out to determine the antimicrobial efficacy of five metals, both individually 
and in combination against E. faecium, K. pneumoniae and A. baumannii planktonic or biofilm phenotypes. The 
potential future use of such antimicrobials would be as biocidal agents for use where intensive cleaning solutions 
were required.
Results
Zone of inhibition (ZoI) for single and combined metals. Zones of inhibition assays were used to 
determine the antimicrobial efficacies of the metal ions in a semi-solid media. Zone of inhibition assays using 
the individual or combined metal solutions, demonstrated an increase in antimicrobial activity which correlated 
with increased metal ion solution concentration (p < 0.001) (Fig. 1). When used individually, platinum, gold 
and palladium demonstrated the greatest ZoIs against all tested microbes (>5 mm and <11 mm) at 1000 mgL−1 
concentration. Copper demonstrated the lowest antimicrobial efficacies, (>2 mm and <4 mm ZoI) at 1000 mgL−1 
concentration. Against E. faecium, only silver and gold exhibited antimicrobial activity at lower concentrations 
(50 mgL−1) (3 mm and 1 mm respectively).
In order to determine the synergies of the metal ions, they were tested using ZoI assays in combination. It 
was demonstrated (Table 1), that the metal solutions gold/platinum, gold/palladium and platinum/palladium 
were most effective antimicrobial combinations and demonstrated synergy at the higher concentrations tested 
(Fig. 2b). However, most of the metal ion combinations tested using ZoI assays demonstrated an indifferent 
response (Fig. 2a). Interestingly at the lower concentration of 100 mgL−1 silver/platinum, silver/gold and silver/
palladium demonstrated antimicrobial activities equivalent to gold/platinum, gold/palladium and platinum/pal-
ladium (Table 1).
Minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) for sin-
gle metals. Following the MIC tests, the most effective antimicrobial metal ion solutions were found to be 
platinum against K. pneumoniae (3.90 mgL−1), silver and gold (3.90 mgL−1) against A. baumannii and platinum 
and gold against E. faecium (11.71 mgL−1) (Table 2). A similar pattern was demonstrated for the MBC with the 
Figure 1. Zone of inhibition values for five metals at different concentrations against tested three pathogens 
demonstrating that at higher concentrations platinum, gold and palladium were the most effective 
antimicrobials whereas at lower concentrations silver demonstrated the greatest antimicrobial activity 
(p < 0.001). Au = gold, Cu = copper, Pt = platinum, Pd = palladium and Ag = silver. 50, 100, 500 and 1000 are at 
concentrations in mgL−1 (n = 12).
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greatest bactericidal activity for platinum, gold and palladium at 3.90 mgL−1 against K. pneumoniae, 5.85 mgL−1 
(gold) and 7.81 mgL−1 (platinum and palladium) against A. baumannii and 31.25 mgL−1 (gold, platinum and pal-
ladium) against E. faecium. Silver showed equable antimicrobial efficacy as platinum, gold and palladium against 
A. baumannii (≤7.81 mgL−1) and moderate efficacy against rest two pathogens. Copper was found to be the least 
active with an antimicrobial efficacy at 15.62 mgL−1 against the two Gram-negative bacteria and 125.00 mgL−1 
against E. faecium (Table 3).
Fractional inhibitory concentration (FIC) for metal combinations. The FIC was used to determine 
the synergistic antimicrobial efficacy of the metals in combination in a solution. The FIC determined that the sil-
ver/palladium combination against E. faecium and silver/copper combination against A. baumannii demonstrated 
AgCu AgPt AgAu AuPd CuPt CuAu CuPd AuPt AuPd PtPd
50 mgL−1
E. faecium 0 0 0 0 0 0 0 0 0 0
A. baumannii 1 2 2 2 1 1 1 2 2 2
K. pneumoniae 1 2 2 2 1 1 1 2 2 2
100 mgL−1
E. faecium 1 2 2 2 1 1 1 2 2 2
A. baumannii 1 2 2 2 1 1 1 4 4 4
K. pneumoniae 1 2 2 2 1 1 1 4 4 4
500 mgL−1
E. faecium 2 3 3 3 3 3 3 4 4 4
A. baumannii 4 5 5 5 4 4 4 6 6 6
K. pneumoniae 4 5 5 5 4 4 4 6 6 6
1000 mgL−1
E. faecium 4 4 4 4 4 4 4 6 6 6
A. baumannii 4 6 6 6 6 6 6 8 8 8
K. pneumoniae 4 6 6 6 6 6 6 8 8 8
Table 1. Zone of inhibition assays for metal combinations against E. faecium, A. baumannii and K. pneumoniae 
(mm) demonstrating that platinum/palladium, gold/palladium or gold/platinum demonstrated the greatest 
antimicrobial activity. Au = gold, Cu = copper, Pt = platinum, Pd = palladium and Ag = silver (n = 3). 
The inhibition zones were graded from 0 to 4, which measured as, 0–4 mm = grade 0, 4–8 mm = grade 1, 
8–12 mm = grade 2, 12–16 mm = grade 3 and 16–20 mm = grade 4.
Figure 2. Examples of combined metals used in ZoI to demonstrate the interactions. (a) Palladium/platinum 
against Gram negative bacteria (indifference interaction) and (b) gold/palladium against E. faecium (synergy 
interaction).
Test samples
K. pneumoniae A. baumannii E. faecium
MIC MBC MIC MBC MIC MBC
Ag 11.71 ± 2.76 11.71 ± 2.76 3.90 ± 0 7.81 ± 0 15.62 ± 0 62.50 ± 0
Cu 15.62 ± 0 15.62 ± 0 15.62 ± 0 15.62 ± 0 62.50 ± 0 125.00 ± 0
Pt 3.90 ± 0 3.90 ± 0 5.85 ± 1.38 7.81 ± 0 11.71 ± 2.76 31.25 ± 0
Au 5.85 ± 1.38 3.90 ± 0 3.90 ± 0 5.85 ± 1.38 11.71 ± 2.76 31.25 ± 0
Pd 5.85 ± 1.38 3.90 ± 0 7.81 ± 0 7.81 ± 0 15.62 ± 0 31.25 ± 0
Table 2. Minimal inhibitory concentration and minimal bactericidal concentration (mgL−1) values for the 
metals against tested three bacteria demonstrating that platinum and gold displayed the most inhibitory 
concentrations and platinum, gold and palladium demonstrated the most potent MBCs. Au = gold, 
Cu = copper, Pt = platinum, Pd = palladium and Ag = silver (n = 3).
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synergistic antimicrobial efficacy (Table 3) (FIC synergistic value ≤ 0.5). All other metal combinations demon-
strated indifferent FIC activities (FIC > 0.5 < 4.0). No metal ion solution combinations were found to demon-
strate antagonistic interactions (>4.0) against the three tested microbes (Table 3).
Biofilm accumulation assays for single and combined metals. The biofilm assays for the individual 
metal solutions demonstrated excellent antimicrobial efficacies for all the metals at 500 mgL−1 concentration 
against all the three bacteria (Fig. 3a–c). The silver against E. faecium was the only result that demonstrated 
Metal ion 
combinations AgCu AgPt AgAu AgPd CuPt CuAu CuPd AuPt AuPd Ptpd
K. pneumoniae 0.57 ± 0 0.66 ± 0 0.73 ± 0.68 0.73 ± 0.68 0.92 ± 0.68 0.67 ± 0.68 0.90 ± 0 0.83 ± 0 0.66 ± 0 0.83 ± 0
A. baumannii 0.46 ± 0.34 0.61 ± 0.34 0.74 ± 0.34 0.74 ± 0 1.37 ± 1.38 0.62 ± 0 0.73 ± 0 0.83 ± 0 0.74 ± 0 0.57 ± 0
E. faecium 0.62 ± 0 1.16 ± 0 0.58 ± 0 0.37 ± 0.68 0.79 ± 0 0.79 ± 0 1.24 ± 0 1.33 ± 0 2.77 ± 0 1.10 ± 0
Table 3. Fractional inhibitory concentration index for metal ion combinations demonstrating a synergistic 
antimicrobial efficacy for silver/copper against K. pneumoniae and silver/palladium against E. faecium. 
Synergy = <0.5, indifference = 0.5–4.0 or antagonism = >4.0. Au = gold, Cu = copper, Pt = platinum, 
Pd = palladium and Ag = silver (n = 3).
Figure 3. (a–c) Biofilm growth in the presence of metal ions tested individually and in combination at 
500 mgL-1 against (a) K. pneumoniae, (b) A. baumannii and (c) E. faecium using crystal violet biofilm assay. The 
metals were tested in a 1:1 ratio. Au = gold, Cu = copper, Pt = platinum, Pd = palladium and Ag = silver (n = 3).
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partial antimicrobial activity. Synergistic assays against the biofilms demonstrated that at the greatest concentra-
tion (500 mgL−1) gold/palladium, gold/platinum and platinum/palladium resulted in the greatest antimicrobial 
efficacy with no detectable biofilm formation against all three tested bacteria along with silver/palladium and cop-
per/gold against K. pneumoniae and silver/palladium against E. faecium. Most of the other metal combinations 
demonstrated partial antimicrobial activity, with only a few demonstrating little antimicrobial activity. None of 
the metal ion combinations demonstrated no antimicrobial activity.
Discussion
With the increase in hospital-acquired infections and the development of multidrug resistant bacteria, it is imper-
ative that new biocidal and antimicrobial formulations are found. Metal compounds and complexes of palladium, 
platinum, copper, gold and silver have been shown to demonstrate effective antimicrobial efficacies against a 
broad range of AMR pathogens5, 6, 10, 19. Metals such as silver in wound dressings, copper on touch surfaces of 
patient equipment and gold and palladium coatings on catheters are considered to possess potential antimicrobial 
properties to reduce bacterial infection and transmission risks24–26. However, few studies have demonstrated the 
antimicrobial efficacy of platinum, gold and palladium in their ionic forms or in combination, although their 
complexes (tetradentate macrocyclic, cisplatin, etc.) have been shown to demonstrate inhibition against bacterial 
pathogens27–29.
As expected, concentration played a pivotal role in increasing the antimicrobial activity in the present study. 
Similar results have been demonstrated by others for complexes containing N-(thiophen-2-ylmethylene)benzo[d]
thiazol-2-amine schiff bases with copper, zinc, cobalt and nickel whereby antimicrobial efficacy increased with 
increasing concentrations (from 5 mgL−1 to 20 mgL−1)30. Copper, nickel and cobalt combined with coumarin-8-yl 
ligands have also showed greater bacterial inhibition at 100 mgL−1 compared to 25 mgL−1 or 50 mgL−1 against K. 
pneumoniae31. This is probably due to the greater quantity of metal ions resulting in increased metal-bacterial 
interactions, leading to increased cell death14.
Overall, platinum, gold and palladium demonstrated the greatest antimicrobial efficacies against both plank-
tonic bacteria and biofilms. However, in its ionic form, copper demonstrated little antimicrobial effect against 
cells or biofilms. In our work, which used metal ions in solution, the most electronegative metals produced the 
best antimicrobial results overall. This may be a result of the high electronegativity of the metal ions being highly 
attracted to the negatively charged bacteria. The result of these highly attractive forces may result in increased 
bacterial-metal ion interactions leading to greater antimicrobial efficacy and thus increased cell death.
Although copper and silver are known antimicrobials these were not the most active metal ion solutions 
tested. The platinum, gold and palladium being the most effective antimicrobials was determined in all the assays, 
except in the results from the FIC. The FIC demonstrated that the silver combinations (silver/palladium against E. 
faecium and silver/copper against A. baumannii), demonstrated the most antimicrobial synergistic combination. 
This might be since, in our work the metal ions were in solutions whereas work by others usually involves the 
investigation of the antimicrobial efficacy of the metals in the form of surfaces, nanoparticles or complexes and it 
is known that the form of the metal will affect the antimicrobial mechanism of action. Although the MIC, MBC 
and FIC were carried out in liquid media, it may be that when the metals were combined as in the FIC, the metal 
ions interacted in a different way, resulting in the silver having a predominant effect. However, the reason for the 
FIC result with the silver is unclear and requires further investigation but it may be due to the principal oxidation 
state of the silver. What is clear is that the assay used does influence the results and one assay alone should not be 
used to determine the overall antimicrobial efficacy of a compound.
Platinum nanoparticles have demonstrated antimicrobial efficacies against Bacillus subtilis, Staphylococcus 
aureus, Pseudomonas aeruginosa and Escherichia coli32 whereas others have found no effect33. A study tested the 
antibacterial properties of nine different metal surfaces against S. aureus and E. coli and found that in agreement 
with our results, palladium demonstrated greater antimicrobial efficacy than the other metals tested34. A study 
by Kawakami et al. (2008) also looked at the antimicrobial efficacy of a number of metals including platinum and 
palladium and it was found that they were effective against E. coli. However, in contrast to our results, their study 
found that gold demonstrated little effect against E. coli or S. aureus35. However, gold in nanoparticle and ionic 
form has been suggested to have antimicrobial activity12, and gold nanoparticles have also been shown to inhibit 
biofilm formation36. Although not as effective in our study, silver in other forms has demonstrated antimicrobial 
efficacy. Silver alginate has been shown to have antimicrobial efficacy against bacterial species isolated from burn 
wounds including A. baumannii, K. pneumoniae and E. faecium25, 37. It is also well known that copper surfaces 
have antimicrobial efficacy against a wide range of microbes38–40.
The differing toxic effects of metals and their components on bacteria can be due to various mechanisms 
such as antioxidant depletion, deoxyribonucleic acid (DNA) damage, impaired membrane function and/or 
interference with nutrient assimilation2. The most common hypothesis for the antimicrobial action of silver 
involves silver ions binding to the proteins and enzymes in the cell wall, cell membrane and peptidoglycan. This 
causes structural changes in the cell wall, such as pits. This increases cell permeability, leading to distortion and 
finally lysis of the cells40–42. Another antimicrobial mechanism of silver is its ability to inter-chelate with the 
phosphorus elements in bacterial DNA, which results in impaired ability to replicate and express ribosomal 
subunit proteins and other cellular proteins43–45. Platinum’s primary cisplatin target is DNA but it also has an 
affinity for the sulphur and selenium donors present in many proteins46, 47. A palladium complex with 1,6-bis(be
nzimidazol-2-yl)-3,4-dithiahexane was thought to exhibit bacterial toxicity mechanisms due to metal protein 
binding leading to DNA damage, causing cell death. Although the chemistry of palladium is very similar to 
that of platinum, palladium complexes differ from those of platinum in several respects. Palladium exhibits a 
greater propensity to exchange ligands, which is about 105 times higher than platinum48. The ligand dissociation 
generates active metal species that can easily interact with other compounds, thus palladium complexes are 
toxic because of their higher reactivity48. The mechanistic action of gold is thought to be due to strong cationic 
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attractions to the negatively charged plasma membrane of microbes which leads to cell membrane disruption, 
Reactive Oxygen Species (ROS) accumulation and consequent cell death35, 49. Copper ions released from copper 
alloys have been suggested to target bacteria by increasing ROS production and thus inducing DNA damage. 
However, this concept is controversial as it has further been demonstrated that disruption of the cell envelope 
is the mode of action of contact killing mediated by dry metallic copper surfaces38. In terms of our results, this 
concept holds true and would in part explain the low antimicrobial results when the copper was in solution. 
Further, there are significant differences that exist between the exposure of bacteria to copper ions and exposure 
to metallic copper surfaces, since the cells on dry metallic copper surfaces are not in an environment that pro-
motes growth. Therefore, these cells face challenges that are different from those in an aqueous environment38. 
It has also been suggested that the antibacterial property of copper ions do not act like some other metals ions 
such as silver50. Thus, it may be that when the bacteria are in direct contact with copper surfaces an enhanced 
antimicrobial effect is achieved.
To the author’s knowledge, studies showing the antimicrobial efficacies of individual and combined metal 
ions has been little researched. A metal’s antimicrobial mechanistic activity is dependent on its chemical 
properties (for example donor atom selectivity, reduction potential), which govern their reactivity in bacte-
rial cells. Thus, using antimicrobial agents in combination may further increase their antimicrobial efficacy 
by producing a synergistic effect51–53. In agreement with our results, work by others has also demonstrated 
that silver ions showed a lower MBC value for E. coli planktonic cells than for biofilms54. Since the physi-
ology, gene expression and morphology of planktonic cells differs from those cells in biofilms, the differ-
ence in the efficacy of the antimicrobial agents against the bacteria in their different states might not be that 
unexpected53–55.
Conclusion
In this pilot study, gold, platinum and palladium demonstrated the most effective antimicrobial activity overall 
for individual metal ion solutions against both planktonic or biofilm phenotypes for three pathogens and could 
potentially be used in biocidal formulations where intensive cleaning is required. The synergistic combinations of 
gold/platinum, gold/palladium and platinum/palladium have the potential to be used in a range of antimicrobial 
or biocidal combinations, particularly against the medically-relevant pathogens tested in this study. Other metals 
demonstrated some antimicrobial and synergistic activity under certain conditions and against particular cells. 
Overall platinum demonstrated the greatest antimicrobial efficacy. The results suggest that when used as potential 
antimicrobials, the combinations selected must be tested towards bacteria in their relevant physiological states. 
It should be noted that the results of this preliminary study were only carried out against one strain of each bac-
terial species and hence future work will investigate the antimicrobial effects of the metal ions against a range of 
bacterial isolates.
Methods
Cultures and Media. Stock cultures of K. pneumoniae strain NCTC9633 and A. baumannii strain 12156 
were subcultured onto Nutrient agar (NA) and incubated at 37 °C for 24 h. E. faecium strain NCTC7171 was 
subcultured onto columbia blood agar (Oxoid, UK) supplemented with 5% defibrinated horse blood in a 5% CO2 
incubator for 24 h at 37 °C. Brain heart infusion (BHIA) agar (Oxoid, UK) and brain heart infusion broth (BHIB) 
(Oxoid, UK) were used for all the microbiological tests for E. faecium. Nutrient agar and nutrient broth (NB) 
(Oxoid, UK) were used to perform all the assays for K. pneumoniae or A. baumanii. Gram-negative microorgan-
isms were incubated at 37 °C overnight in an aerobic atmosphere whilst E. faecium was incubated in a 5% CO2 
incubator for 24 h at 37 °C in static conditions for all the other assays in this study. All the assays were repeated at 
least thrice (n = 3).
Chemical Preparation. Single element standard calibration solutions for Ion Coupled Plasma – 
Atomic Adsorption Spectroscopy (ICP-AAS) of 1000 mgL−1 of silver, copper, platinum, gold and palladium 
(Sigma-Aldrich, UK) were used. These were diluted with sterile water to the respective metal ion concentrations.
Bacterial preparation. Ten millilitres of appropriate broth was put into a sterile universal for the Zone of 
inhibition (ZoI) assays. One hundred and fifty millilitres of appropriate broth was put into a conical flask for 
minimum inhibitory concentrations (MIC), minimum bactericidal concentration (MBC) and fractional inhib-
itory concentration (FIC) and crystal violet biofilm assays (CVBAs). These were inoculated with a single colony 
of bacteria and incubated overnight according to the conditions in the culture and media sub-section. Cells were 
harvested by centrifugation (3500 g for 10 min) and then washed with 10 mL sterile distilled water and vortexed 
to ensure an even distribution of the cell suspension. The washed cells were again re-harvested. The pellet was 
re-suspended in 10 mL of broth, vortexed and the resultant cell suspension was adjusted to an optical density 
at 540 nanometres (nm) (OD540) of 1.0 using a spectrophotometer. The cell concentration corresponded to 
3.95 × 108 colony-forming units per mL (CFUmL−1) at an OD540 of 1.0.
Zone of inhibition assays. Respective agar was poured into sterile Petri dishes, which were then cooled 
and 100 μL of cell suspension was pipetted and spread across the entire area of the agar. Three equal wells (8 mm 
diameter) were cut out of the each agar plate using a sterile cork borer and stainless steel needle. To each of the 
wells, 100 μL of the metal ion solution was added. The plates were incubated as mentioned in cultures and media 
sub-section. The ZoI was measured using the different metal ion solution concentrations, 50 mgL−1, 100 mgL−1, 
500 mgL−1 and 1000 mgL−1. Following incubation, the ZoI was measured in mm from four sides of each well to 
determine an average mean value (n = 12).
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Zone of inhibition assays (synergy). For the synergy assays, the same method was carried out as above 
(zone of inhibition) except that two wells were cut from the agar, 6 mm apart (n = 3). The concentration of the 
metal ions used in the ZoI synergy assays was 50 mgL−1, 100 mgL−1, 500 mgL−1 and 1000 mgL−1. Following incu-
bation, the inhibition zones were graded from 0 to 4, which measured as, 0–4 mm – grade 0, 4–8 mm – grade 1, 
8–12 mm – grade 2, 12–1 6 mm – grade 3 and 16–20 mm – grade 4. The grade of inhibition of the metal ion solu-
tion combinations were calculated as follows;
Σ = +metal ion solution combination first metal grade of inhibition second metal grade of inhibition (1)
Individual metal ion MIC and MBC assays. One millilitre of Triphenyl tetrazolium chloride (TTC) blue 
metabolic dye (Sigma-Aldrich, UK), was added into 9 mL of the OD adjusted cell suspension so that the working 
concentration of the dye was 0.15% w/v. To determine the MIC, 100 μL of the test samples were added to a 96 well 
flat-bottomed microtiter plate (MTP). One hundred microliters of bacterial suspension with the TTC dye was 
then added; the first column of cell/metal ion suspension was mixed, then 100 μL of the sample/bacterial mix was 
transferred to the column 2 wells and repeated until column 10. To column 11, 100 μL of bacterial suspension 
without a metal (positive control) was added and to column 12 and 100 μL of un-inoculated broth was added 
(negative control). After incubation, the MIC was taken as lowest concentration that inhibited the visible growth 
of the bacteria by comparison with the controls. Growth was indicated by a change of colour in the well to dark 
blue/purple. Twenty-five microliters of culture was taken from the first well that showed no growth and the last 
well that demonstrated growth and was pipetted onto agar plates using Miles and Misra methodology56, 57 (n = 3). 
After incubation, the lowest concentration well sample that showed no bacterial growth on the agar plate was 
determined to be the MBC for that test sample (n = 3).
Fractional inhibitory concentrations assay. The bacterial suspension and test samples for the FIC test 
were prepared as described in the sub-section culture and media and MIC method, except that both metal ion 
solutions were added to the wells in a 1:1 ratio. Following incubation at 37 °C for 24 h, the FIC values were calcu-
lated as;
Σ = +
=
+
FIC FIC of antimicrobial A FIC of antimicrobial B
MIC of antimicrobial A in combination
MIC of antimicrobial A alone
MIC of antimicrobial B in combination
MIC of antimicrobial B alone (2)
depending on the FIC values, the antimicrobial interaction was evaluated as synergy = <0.5, indiffer-
ence = 0.5–4.0 or antagonism = >4.0 (n = 3).
Crystal Violet Biofilm Assay (CVBA). Preparation of stainless steel coupons. Fine polished (FP) 304 
grade stainless steel coupons (10 mm × 10 mm) were used in the assays. Coupons were washed thoroughly by 
sequentially putting the coupons into beakers each containing either acetone, methanol or ethanol (BDH, UK) for 
10 min with a sterile water wash in between each, and for the final step. The washed coupons were air dried and 
stored in sealed plastic containers at room temperature until used.
Biofilm formation and CVBA (adapted from Christen et al. 1985). The cell suspension was prepared in the same 
manner as described in culture and media sub-section. Twelve well culture plates were used to grow the biofilms. 
Cleaned coupons were placed in the centre of the well with the fine polished surface facing upward. One millilitre 
of adjusted OD cell suspension was added to each well and incubated for 7 days at 37 °C to produce a biofilm. 
Plates were wrapped in ParafilmTM to prevent moisture loss and air contaminants over the long incubation time. 
After incubation, the stainless-steel coupons were carefully washed with 2 mL of sterile distilled water using a 
pipette to remove any loose planktonic cells whilst avoiding damaging the biofilms. The coupons were air dried 
at room temperature for 2 h. One millilitre of metal ion solution at 500 mgL−1 was added into each respective 
well. Respective agar broths were also added into one of the wells to serve as a negative control. The plates were 
incubated for 24 h at 37 °C. Following incubation, the metal ion solutions were removed. The coupons were care-
fully washed with 1 mL of sterile distilled water and were air dried at room temperature. One millilitre of 0.03% 
crystal violet solution (Oxoid, UK) was added into each well with a coupon and left for 30 min. The coupons 
were gently washed with 2 mL sterile distilled water to remove any excess stain. The coupons were placed into 
new 12 well plates and air dried at room temperature for 1 h. One millilitre of 33% glacial acetic acid (BDH, UK) 
was added to each well and left for 30 min to solubilise any stained biofilm. The solution was removed and the 
absorbance measured at OD590 (n = 3). Bacterial biofilms were divided into breakpoint categories; OD < 0.067 
antimicrobial; OD ≥ 0.068 but ≤ 0.135 partial antimicrobial activity; ≥OD 0.136–≤0.270 negligible antimicrobial 
activity; >0.271 no antimicrobial activity. These values were determined using quartiles of the lowest OD value 
determined from the control.
Statistical analyses. Mean values were used to compare the antimicrobial efficacy results of the metal ion 
solution samples at varying concentrations. Standard deviation or standard error were calculated to analyse the 
distributions of the data from the mean value, and confidence intervals of 95% were calculated for the ZoI, FIC 
and MBC synergy tests results to plot error bars.
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